Article info
Case report
Fatal hepatotoxicity due to sevoflurane use in a paediatric patient after aortic repair: reality or fiction? A case of pharmacovigilance
- Correspondence to Dr Andrea Zovi, DISFARM Department of Pharmaceutical Sciences, University of Milan, Milano 7, 20122, Lombardia, Italy; andrea.zovi{at}asst-santipaolocarlo.it
Citation
Fatal hepatotoxicity due to sevoflurane use in a paediatric patient after aortic repair: reality or fiction? A case of pharmacovigilance
Publication history
- Received November 17, 2020
- Revised February 28, 2021
- Accepted March 9, 2021
- First published April 8, 2021.
Online issue publication
October 18, 2023
Article Versions
- Previous version (19 December 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© European Association of Hospital Pharmacists 2023. No commercial re-use. See rights and permissions. Published by BMJ.